Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Moderna shares hit a low after report suggests the FDA plans to tie COVID shots to child deaths
09:11am, Monday, 15'th Sep 2025
Pharma stocks took a fresh hit on Friday following a report in The Washington Post that the U.S. Food and Drug Administration reportedly plans to link COVID-19 vaccines with the deaths of 25 minors.
Moderna (MRNA) Declines More Than Market: Some Information for Investors
06:46pm, Friday, 12'th Sep 2025
Moderna (MRNA) reached $23.51 at the closing of the latest trading day, reflecting a -7.4% change compared to its last close.
S&P 500 Gains and Losses Today: Warner Bros. and Paramount Extend Gains; Moderna Plunges
06:25pm, Friday, 12'th Sep 2025
Shares of two entertainment giants pushed higher for a second straight day as investors weighed the possibility of a takeover bid, while vaccine makers came under pressure following a report that heal
Pfizer, Moderna shares plunge on report that Trump officials plan to link 25 child deaths to COVID vaccine
04:46pm, Friday, 12'th Sep 2025
Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively.
COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says
01:37pm, Friday, 12'th Sep 2025
Shares of companies that make COVID vaccines sank Friday, after a report raised fears that Trump administration health officials will blame the vaccines for some child deaths.
Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots
12:21pm, Friday, 12'th Sep 2025
Shares of Pfizer and Moderna fell on Friday after a report that Trump administration health officials plan to link Covid vaccines to the deaths of 25 children. The report comes as Health and Human S
Trump officials to link child deaths to covid shots, according to reports
12:18pm, Friday, 12'th Sep 2025
CNBC's Angelica Peebles joins 'Money Movers' to discuss Trump officials reported plan to link child deaths to covid shots.
Moderna, Inc. (MRNA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
01:14pm, Monday, 08'th Sep 2025
Moderna, Inc. (NASDAQ:MRNA ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 10:00 AM EDT Company Participants Stéphane Bancel - CEO & Director Conference Call Participants
Is it Time to Dump Your Shares of Moderna?
04:42am, Sunday, 07'th Sep 2025
Although you may not exactly understand what Moderna (MRNA 3.54%) does, you probably know the company's name, given its involvement in the coronavirus pandemic. The messenger RNA technology, or mRNA,
Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism
07:00am, Tuesday, 02'nd Sep 2025
CAMBRIDGE, MA / ACCESS Newswire / September 2, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that five abstracts on its investigational mRNA therapeutics have been accepted for presentation at th
What Moved Markets This Week
06:49am, Saturday, 30'th Aug 2025
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
FDA Approves Updated COVID-19 Vaccines but With Restrictions
01:06pm, Thursday, 28'th Aug 2025
FDA clears updated COVID-19 vaccines from Pfizer, Moderna and Novavax but limits access to older adults and high-risk groups.
IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies
08:00am, Thursday, 28'th Aug 2025
RESEARCH TRIANGLE PARK, N.C. and CAMBRIDGE, Mass.
mRNA Biotechs - Long-Term Value Risks Abound
06:20am, Thursday, 28'th Aug 2025
mRNA vaccine companies are overhyped post-pandemic, facing scientific, operational, and regulatory headwinds that limit long-term investment appeal. Scientific and business risks, including delivery c
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2
01:24pm, Wednesday, 27'th Aug 2025
CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Applica
